biological source
mouse
conjugate
unconjugated
antibody form
purified from hybridoma cell culture
antibody product type
primary antibodies
clone
ANX47, monoclonal
form
buffered aqueous solution
mol wt
antigen 34 kDa
species reactivity
mouse, bovine, human, monkey
packaging
antibody small pack of 25 μL
concentration
~1.5 mg/mL
technique(s)
immunohistochemistry: suitable, western blot: 2-4 μg/mL using A431 total cell extracts
isotype
IgG1
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... ANXA4(307)
General description
Annexin A4 is encoded by the gene mapped to human chromosome 2p13.3. The encoded protein belongs to the Ca2+-regulated and phospholipid-binding annexin superfamily proteins. Annexin A4 is highly expressed in epithelial cells.
Monoclonal Anti-Annexin 4 (mouse IgG1 isotype) is derived from the hybridoma ANX47 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a recombinant human Annexin 4 protein.
Immunogen
recombinant human Annexin 4 protein
Application
The product may be used in several immunochemical techniques including immunoblotting and immunohistochemistry.
Biochem/physiol Actions
Elevated expression of annexin A4 leads to development of various cancers such as colorectal cancer (CRC), esophageal squamous cell carcinoma (ESCC), endometrial carcinoma (EC), gastric cancer (GC), chemoresistant lung cancer (LC), malignant mesothelioma (MM), renal cell carcinoma (RCC), ovarian clear cell carcinoma (OCCC), cholangiocarcinoma, hepatocellular carcinoma (HCC), breast cancer (BC) and laryngeal cancer. Thus, annexin A4 can be used in diagnosis, prognosis and treatment of these cancers. In addition, the encoded protein acts as a tumor suppressor for prostate cancer (PCa) and has a contradictory role for pancreatic cancer (PCC).
The major involvement of Annexin 4 is seen in membrane permeability, exocytosis and regulation of ion channels. Its role in membrane fluidity and membrane trafficking may explain in part the involvement of Annexin 4 in modulating drug resistance in cancer cells. Indeed, Annexin 4 was found to confer chemoresistance in ovarian cancer cells in part by enhancing drug efflux.
Physical form
Solution in 0.01M phosphate buffered saline pH 7.4, containing 15 mM sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
低风险生物材料
此项目有
Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin
Kim A, et al.
International Journal of Cancer. Journal International Du Cancer, 125(10), 2316-2322 (2009)
Annexin A4 and cancer.
Wei B
Clinica Chimica Acta; International Journal of Clinical Chemistry, 447, 72-78 (2015)
Proteome of the early embryo-maternal dialogue in the cattle uterus
Munoz M, et al.
Journal of Proteome Research, 11(2), 751-766 (2011)
Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel
Gaudio E
PLoS ONE (2013)
Gene Expression and Proteomic Analysis of Pancreatic Cancer: a Recent Update
CHEN R U
Cancer, Genomics, and Proteomics, 1-10 (2006)
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持